16-fluoroestradiol has been researched along with Bone Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dunnwald, LK; Ellis, GK; Gralow, JR; Krohn, KA; Linden, HM; Link, JM; Livingston, RB; Mankoff, DA; Peterson, LM; Petra, PH; Schubert, EK; Stekhova, SA | 1 |
1 other study(ies) available for 16-fluoroestradiol and Bone Cancer
Article | Year |
---|---|
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Salvage Therapy; Tamoxifen | 2006 |